Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review

Background: Several clinical studies have been undertaken to investigate the potential therapeutic effects of Silybum marianum (S. marianum) seed extract (silymarin) in Type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). Objective: We performed the present narrative review...

Full description

Bibliographic Details
Main Authors: Sayed Mohammad Mohammadi, Saeed kianbakht, Shamsali Rezazadeh, Mojtaba Ziaee, Hasan Fallah Huseini
Format: Article
Language:English
Published: Institue of Medicinal Plants, ACECR 2020-03-01
Series:Journal of Medicinal Plants
Subjects:
Online Access:http://jmp.ir/article-1-2322-en.html
_version_ 1818725944414699520
author Sayed Mohammad Mohammadi
Saeed kianbakht
Shamsali Rezazadeh
Mojtaba Ziaee
Hasan Fallah Huseini
author_facet Sayed Mohammad Mohammadi
Saeed kianbakht
Shamsali Rezazadeh
Mojtaba Ziaee
Hasan Fallah Huseini
author_sort Sayed Mohammad Mohammadi
collection DOAJ
description Background: Several clinical studies have been undertaken to investigate the potential therapeutic effects of Silybum marianum (S. marianum) seed extract (silymarin) in Type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). Objective: We performed the present narrative review to evaluate the efficacy of silymarin supplement for treatment of T2DM and NAFLD. Methods: Electronic databases PubMed, Science Direct, Scopus, Google and Google Scholar were surveyed for the English and non-English human clinical trial papers published concerning the effects of silymarin on T2DM and NAFLD from January 2010 to April 2018. Results: Sixteen articles regarding silymarin effects on T2DM and NAFLD in clinical studies have been included in this review. The anti-diabetic effect of silymarin was reported in four clinical trials in single formula and in one trial in combination with nettle and boswellia gum resin. The efficacy of silymarin or silybin has been reported in the treatment of NAFLD in eleven clinical trials as single formula or in combination with phosphatidylcholine, simvastatin and vitamin E. Conclusion: Silymarin appears to be effective as an adjuvant with the standard therapy in the treatment of T2DM and NAFLD.
first_indexed 2024-12-17T21:50:21Z
format Article
id doaj.art-1f275665290d4e0296a4688ab26e9a1f
institution Directory Open Access Journal
issn 2717-204X
2717-2058
language English
last_indexed 2024-12-17T21:50:21Z
publishDate 2020-03-01
publisher Institue of Medicinal Plants, ACECR
record_format Article
series Journal of Medicinal Plants
spelling doaj.art-1f275665290d4e0296a4688ab26e9a1f2022-12-21T21:31:20ZengInstitue of Medicinal Plants, ACECRJournal of Medicinal Plants2717-204X2717-20582020-03-0119731226Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative reviewSayed Mohammad Mohammadi0Saeed kianbakht1Shamsali Rezazadeh2Mojtaba Ziaee3Hasan Fallah Huseini4 Department of Internal Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran Background: Several clinical studies have been undertaken to investigate the potential therapeutic effects of Silybum marianum (S. marianum) seed extract (silymarin) in Type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). Objective: We performed the present narrative review to evaluate the efficacy of silymarin supplement for treatment of T2DM and NAFLD. Methods: Electronic databases PubMed, Science Direct, Scopus, Google and Google Scholar were surveyed for the English and non-English human clinical trial papers published concerning the effects of silymarin on T2DM and NAFLD from January 2010 to April 2018. Results: Sixteen articles regarding silymarin effects on T2DM and NAFLD in clinical studies have been included in this review. The anti-diabetic effect of silymarin was reported in four clinical trials in single formula and in one trial in combination with nettle and boswellia gum resin. The efficacy of silymarin or silybin has been reported in the treatment of NAFLD in eleven clinical trials as single formula or in combination with phosphatidylcholine, simvastatin and vitamin E. Conclusion: Silymarin appears to be effective as an adjuvant with the standard therapy in the treatment of T2DM and NAFLD.http://jmp.ir/article-1-2322-en.htmlclinical trialdiabetes mellitusfatty liversilymarin
spellingShingle Sayed Mohammad Mohammadi
Saeed kianbakht
Shamsali Rezazadeh
Mojtaba Ziaee
Hasan Fallah Huseini
Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review
Journal of Medicinal Plants
clinical trial
diabetes mellitus
fatty liver
silymarin
title Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review
title_full Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review
title_fullStr Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review
title_full_unstemmed Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review
title_short Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review
title_sort clinical efficacy of silybum marianum seed extract in treatment of type 2 diabetes mellitus and non alcoholic fatty liver disease a narrative review
topic clinical trial
diabetes mellitus
fatty liver
silymarin
url http://jmp.ir/article-1-2322-en.html
work_keys_str_mv AT sayedmohammadmohammadi clinicalefficacyofsilybummarianumseedextractintreatmentoftype2diabetesmellitusandnonalcoholicfattyliverdiseaseanarrativereview
AT saeedkianbakht clinicalefficacyofsilybummarianumseedextractintreatmentoftype2diabetesmellitusandnonalcoholicfattyliverdiseaseanarrativereview
AT shamsalirezazadeh clinicalefficacyofsilybummarianumseedextractintreatmentoftype2diabetesmellitusandnonalcoholicfattyliverdiseaseanarrativereview
AT mojtabaziaee clinicalefficacyofsilybummarianumseedextractintreatmentoftype2diabetesmellitusandnonalcoholicfattyliverdiseaseanarrativereview
AT hasanfallahhuseini clinicalefficacyofsilybummarianumseedextractintreatmentoftype2diabetesmellitusandnonalcoholicfattyliverdiseaseanarrativereview